| 9/27/2012 | BKCVIG | Fitch lowers Watson
|
| 9/27/2012 | BKCVIG | S&P rates Watson notes BBB
|
| 9/27/2012 | CVIGPF | Watson files automatic shelf for stock, preferreds and debt securities
|
| 6/27/2012 | BKCVIG | Fitch rates Watson loan BBB
|
| 4/25/2012 | CVIG | Moody's: Watson view stable
|
| 8/9/2010 | CVIG | Fitch ups Watson Pharmaceuticals
|
| 6/8/2010 | CVHY | Moody's lifts Watson from junk
|
| 8/28/2009 | CV | Market Commentary: AMD extends gains after Intel raises forecast; Intel also higher; E*Trade active after swap deal
|
| 8/25/2009 | CV | Watson announces redemption of 1.75%, variable-rate convertibles
|
| 8/19/2009 | CV | Market Commentary: Johnson Controls rises to well above double par; D.R. Horton slips; Watson, Saks active
|
| 8/18/2009 | BKCV | Moody's affirms Watson
|
| 8/18/2009 | BKCV | Fitch affirms Watson
|
| 8/18/2009 | CV | Watson plans to redeem convertibles, pay down portion of term loan
|
| 8/18/2009 | CV | Market Commentary: Allegheny Technologies trades lightly; Saks mostly flat after smaller-than-expected loss
|
| 8/17/2009 | CVIG | Watson files automatic shelf for debt securities, preferreds and stock
|
| 7/27/2009 | CV | Market Commentary: Ford careens higher; Webster boosted by PIPE investment; Mylan mostly firm as shares drop
|
| 6/18/2009 | BKCV | Fitch affirms Watson
|
| 6/18/2009 | CV | Market Commentary: Whiting Petroleum slips below par on debut; Watson up; newly priced issues in focus
|
| 6/17/2009 | BKBWCVSS | Watson may refinance convertibles to help fund Arrow acquisition
|
| 6/17/2009 | BKCV | Moody's: Watson loans on review uncertain
|
| 5/26/2009 | BKCV | Moody's: Watson outlook positive
|
| 4/22/2009 | CV | Market Commentary: Watson, OSI add on buyout rumors; Alexandria up; Ford jumps, GM mixed; Old Republic to price
|
| 3/3/2009 | CV | Market Commentary: Ford lower, GM mixed; financials, Prudential under pressure; Watson Pharmaceuticals stronger
|
| 2/19/2009 | CV | Market Commentary: Financials extend losses; Wells Fargo preferreds sink to 400; Watson in focus after better earnings
|
| 11/25/2008 | CV | Market Commentary: Merrill Lynch sees better buyers; Ford adds, but GM mixed; Charming Shoppes, Watson edge higher
|
| 3/1/2007 | CV | S&P: Watson Pharmaceuticals unaffected
|
| 11/6/2006 | BTCV | Fitch cuts Watson to BBB-
|
| 9/21/2006 | BKBTCVHY | Moody's revises ratings for nine U.S. pharma companies
|
| 8/4/2006 | BKBTCVHY | S&P rates Watson Pharmaceuticals loan BBB-, lowers notes to BB+
|
| 8/4/2006 | BKBTCVHY | Moody's cuts Watson Pharmaceutical convertibles to Ba2, rates loans Ba1
|
| 5/10/2006 | BTCV | S&P keeps Watson on negative watch
|
| 5/9/2006 | CV | Market Commentary: SanDisk deal gains in gray market; Broadwing offering seen as fair; General Motors mixed on upgrade
|
| 3/29/2006 | CV | Market Commentary: Lear gains on financing news, Amdocs strengthens; new issue from AMG fails to enthuse
|
| 3/15/2006 | BKBTCV | Moody's may downgrade Watson
|
| 3/14/2006 | CV | Market Commentary: Fair Isaac plunges on fears of new rival product; Human Genome slides on mixed trial results
|
| 3/13/2006 | BTCV | Fitch puts Watson on negative watch
|
| 3/13/2006 | CV | Market Commentary: Lear surges on rumored refinancing; Apex Silver slides on probe; Watson falls on takeover
|
| 3/13/2006 | BTCV | S&P puts Watson on negative watch
|
| 2/23/2006 | BTCV | Fitch affirms Watson
|
| 1/5/2006 | CV | Market Commentary: Convertible market extends broad-based gains; autos, biotechs lift; Fannie Mae adds
|
| 12/9/2005 | CV | Market Commentary: Cephalon, Teva gain on patent settlement; eyes turn toward Omnicare; Alltel mostly quiet
|
| 11/4/2005 | CV | Market Commentary: Qwest, Chesapeake remain active; Celgene up, Emdeon lower; King sideways
|
| 11/3/2005 | CV | Market Commentary: Chesapeake, Qwest trade higher; Abgenix, Amgen rise, but ImClone lower; SFBC plunges
|
| 7/7/2005 | CV | Market Commentary: Biotechs up as convertibles find footing after early dip; airlines down; some oil and gas names extend gains
|
| 10/25/2004 | CV | Market Commentary: Armor overnighter slips in gray market; Isolagen, Option Care deals also emerge
|
| 8/30/2004 | CV | Market Commentary: LNR convertible leveled by $1.9 billion cash takeover; United Rentals falls on SEC inquiry
|
| 7/7/2004 | CV | Market Commentary: Omnicom, AMG spiral on new CoCo rule possibility; EDS active on tighter credit
|
| 7/1/2004 | BKCV | Moody's affirms Watson
|
| 7/1/2004 | BKCV | S&P: Watson outlook negative
|
| 6/30/2004 | CV | Market Commentary: Market watches Fed; Allscripts, General Mills and Watson Pharmaceuticals trade
|
| 6/29/2004 | CV | Market Commentary: New liquid paper seen as a nice addition for traders although some sit back waiting on Fed meeting
|
| 3/22/2004 | CV | Fitch upgrades Watson
|
| 12/2/2003 | CV | Fitch: Some issuers may improve balance sheet, ratings with convertibles conversion
|
| 9/25/2003 | CV | Market Commentary: Pharma Resources gains to 104 despite complaint; Bristol-Myers jumbo seen offered at par in gray
|
| 9/24/2003 | CV | Market Commentary: CKE bids beefed up to 107; Flextronics expected to lose "big points" on jury award
|
| 3/24/2003 | CV | Fitch ups GTech outlook
|
| 3/10/2003 | CV | Market Commentary: Interpublic again dominates market attention; new paper weak amid sluggish session
|
| 3/6/2003 | CV | Market Commentary: Raytheon dives on pension costs; some retail issues find buyers on recent weakness
|
| 3/5/2003 | CV | Fitch rates Watson convert BBB-
|
| 3/5/2003 | CV | Market Commentary: Watson trades up out of gate, Provident plunges, call scare ripples throughout market
|
| 3/5/2003 | CV | New Issue: Watson upsizes convertibles to $500 million, yield 1.75%, up 42%
|
| 3/4/2003 | CV | Market Commentary: Inco deals steady out of gate; Watson trading up in gray as credit, put offset pricey terms
|
| 3/3/2003 | CV | Moody's ups American Tower liquidity rating
|
| 3/3/2003 | CV | Market Commentary: Inco prices $400 million, Watson launches quickie; Capital One dives on CFO departure
|
| 3/3/2003 | CV | Watson launches $450 million convertibles talked at 1.75-2.25%, up 38-42%
|
